Cargando…

Endocrinological late effects after chemotherapy for testicular cancer.

Type and extent of endocrinological alterations were studied in long-term disease-free survivors after cisplatin-based chemotherapy for testicular cancer. A total of 63 patients with a median age of 30 (19-53) years, and median follow-up of 42 (16-128) months were included. Elevated serum follicle-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, C. C., Bokemeyer, C., Schuppert, F., Schmoll, H. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074412/ https://www.ncbi.nlm.nih.gov/pubmed/8624272

Ejemplares similares

Long-term effects on sexual function and fertility after treatment of testicular cancer
por: Hartmann, J T, et al.
Publicado: (1999)

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
por: Bokemeyer, C., et al.
Publicado: (1998)

The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna.
por: Bokemeyer, C., et al.
Publicado: (1994)

Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
por: Brydøy, M, et al.
Publicado: (2012)

Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer
por: Bokemeyer, C, et al.
Publicado: (2002)

Endocrinological and Cardiological Late Effects Among Survivors of Childhood Acute Lymphoblastic Leukemia
por: Karakaya, Pakize, et al.
Publicado: (2013)

Long-term toxicity of chemotherapy for testicular cancer--the cost of cure.
por: Stuart, N. S., et al.
Publicado: (1990)

Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
por: Kollmannsberger, C, et al.
Publicado: (2003)

Behavioral Endocrinology
por: Morgan, C.A.
Publicado: (2002)

Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life
por: Mohta, Alpana, et al.
Publicado: (2020)

Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer
por: Cameron, Alan C., et al.
Publicado: (2020)

Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors
por: Boer, H., et al.
Publicado: (2015)

Transient effects of chemotherapy for testicular cancer on mouse behaviour
por: Borbélyová, Veronika, et al.
Publicado: (2020)

Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer
por: Nord, C, et al.
Publicado: (2003)

Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.
por: Steyerberg, E. W., et al.
Publicado: (1993)

Endocrinology in the Time of Coronavirus: A Virtual Endocrinology Elective for Medical Students
por: Moxley, Meaghan C, et al.
Publicado: (2021)

Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.
por: Fosså, S. D., et al.
Publicado: (1990)

Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials
por: Bokemeyer, C, et al.
Publicado: (2004)

Frontiers in Cancer Endocrinology
por: Colao, Annamaria, et al.
Publicado: (2011)

Molecular Endocrinology of Cancer
por: New, John
Publicado: (1997)

First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial
por: Bokemeyer, C, et al.
Publicado: (2003)

Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy
por: Garcia, Sara L., et al.
Publicado: (2023)

Reply: Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy
por: Nord, C, et al.
Publicado: (2003)

Essential endocrinology : a primer for nonspecialists
por: Kannan, C. R. (Charkravarthy R.), 1943-
Publicado: (1986)

Molecular endocrinology /
por: Bolander, Franklyn F.
Publicado: (1994)

Endocrinology
por: Hadley, Mac E.
Publicado: (1996)

Endocrinology /
por: Binkley, Sue Ann, 1944-
Publicado: (1995)

Endocrinology /
Publicado: (2001)

Endocrinology
Publicado: (2011)

Endocrinology
Publicado: (1995)

Endocrinology
Publicado: (1937)

Perceived Positive and Negative Life Changes in Testicular Cancer Survivors
por: Vehling, Sigrun, et al.
Publicado: (2021)

Endocrinology in Pakistan: Transcending in care of endocrinological disorders
por: Raza, S. Abbas
Publicado: (2011)

Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
por: Jacobsen, K D, et al.
Publicado: (1999)

Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer
por: Altena, R, et al.
Publicado: (2009)

Canine and feline endocrinology and reproduction
por: Feldman, Edward C.
Publicado: (1996)

Canine and feline endocrinology and reproduction
por: Feldman, Edward C.
Publicado: (2004)

Exercise Endocrinology: “What Comes Next?”
por: Hackney, Anthony C., et al.
Publicado: (2021)

Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
por: Koch, S, et al.
Publicado: (2003)

Chemotherapy for testicular cancer induces acute alterations in diastolic heart function
por: van Schinkel, L D, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rfu2fcp7jg6sca6ttdun3vtav1